Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.4
IR-Med, Inc. issued warrant.
- Security
- warrant
Exact text from the filing
The information required by this Item 3.02 is included under Item 1.01 of this Current Report on Form 8-K.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
IR-Med, Inc. entered into Securities Purchase Agreement with certain investors valued at aggregate gross proceeds of $43,619 (effective 2026-02-04).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- certain investors
- Value
- aggregate gross proceeds of $43,619
- Effective
- 2026-02-04
Exact text from the filing
On February 4, 2026, IR-Med, Inc. (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain investors (each an “Investor” and, collectively, the “Investors”), pursuant to which the Company agreed to issue and sell, in a private placement offering (the “Offering”), an aggregate of 14,070,644 shares of the Company’s common stock, par value $0.001 per share, (the “Common Stock”), at a per share price of $0.0031 and a warrant to purchase up to an additional 7,035,322 shares of Common Stock (the “Warrants”) at a per share exercise price of $0.03 (the “Exercise Price”).
View on SEC.gov